Literature DB >> 21460727

The economics of telemedicine for vitreoretinal diseases.

Angela Au1, Omesh Gupta.   

Abstract

PURPOSE OF REVIEW: A literature review was conducted presenting the current data on the economics of telemedicine in vitreoretinal diseases. RECENT
FINDINGS: There have been an increasing number of studies evaluating the cost-effectiveness of telemedicine for vitreoretinal diseases. The availability of ophthalmologists able to screen for these conditions is limited. Teleophthalmology has been playing a larger role in screening for diabetic retinopathy, retinopathy of prematurity, and age-related macular degeneration. Many telemedicine programs are currently being investigated and implemented.
SUMMARY: Telemedicine is a cost-effective means for screening diabetic retinopathy and retinopathy of prematurity. It can alleviate some of the burden of this growing public health problem. However, the large initial cost associated with beginning a teleophthalmology retinal screening program is a barrier to implementation. Additional studies are needed in the area of telemedicine for age-related macular degeneration.

Entities:  

Mesh:

Year:  2011        PMID: 21460727     DOI: 10.1097/ICU.0b013e3283459508

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  16 in total

1.  Glaucoma Patient Knowledge, Perceptions, and Predispositions for Telemedicine.

Authors:  Lindsay A Rhodes; Carrie E Huisingh; Gerald McGwin; Christopher A Girkin; Cynthia Owsley
Journal:  J Glaucoma       Date:  2019-06       Impact factor: 2.503

Review 2.  Operational Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

3.  Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics.

Authors:  Eric K Chin; Bruna V Ventura; Kai-Yin See; Joann Seibles; Susanna S Park
Journal:  Telemed J E Health       Date:  2013-11-12       Impact factor: 3.536

Review 4.  The use of retinal photography in nonophthalmic settings and its potential for neurology.

Authors:  Mario A Pérez; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Neurologist       Date:  2012-11       Impact factor: 1.398

5.  Tele-Oncology: A Validation Study of Choroidal and Iris Nevi.

Authors:  Kelsey Roelofs; Ezekiel Weis
Journal:  Ocul Oncol Pathol       Date:  2018-12-13

Review 6.  Teleglaucoma: improving access and efficiency for glaucoma care.

Authors:  Faazil Kassam; Kanagasingam Yogesan; Enitan Sogbesan; Louis R Pasquale; Karim F Damji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

7.  Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: the multicenter Brazilian Type 1 Diabetes Study.

Authors:  Fernando Korn Malerbi; Paulo Henrique Morales; Michel Eid Farah; Karla Rezende Guerra Drummond; Tessa Cerqueira Lemos Mattos; André Araújo Pinheiro; Felipe Mallmann; Ricardo Vessoni Perez; Franz Schubert Lopes Leal; Marília Brito Gomes; Sergio Atala Dib
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

8.  A mobile team for screening of retinopathy of prematurity in India: Cost - effectiveness, outcomes, and impact assessment.

Authors:  Jai Kelkar; Aditya Kelkar; Shubhangi Sharma; Jaya Dewani
Journal:  Taiwan J Ophthalmol       Date:  2017 Jul-Sep

9.  A survey of Alabama eye care providers in 2010-2011.

Authors:  Paul A Maclennan; Gerald McGwin; Karen Searcey; Cynthia Owsley
Journal:  BMC Ophthalmol       Date:  2014-04-03       Impact factor: 2.209

10.  Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) for adults at risk for glaucoma: study rationale and design.

Authors:  Cynthia Owsley; Lindsay A Rhodes; Gerald McGwin; Stephen T Mennemeyer; Mary Bregantini; Nita Patel; Demond M Wiley; Frank LaRussa; Dan Box; Jinan Saaddine; John E Crews; Christopher A Girkin
Journal:  Int J Equity Health       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.